Doctor Leucht is deputy director of the Department of Psychiatry and Psychotherapy of the Technische Universität München, Munich, Germany, where he has practiced since 1994 and where he leads the section of evidence-based medicine in psychiatry. He worked as a research associate at the Zucker Hillside Hospital, in New York in 2002/2003. He spent a year as honorary fellow at the University Department of Psychiatry in Oxford and as visiting professor at the Institute of Psychiatry, King’s College London in 2013/2014. He is part of the editorial teams of several psychiatric journals, including the Cochrane Schizophrenia Group, Lancet Psychiatry, Schizophrenia Research, Schizophrenia Bulletin, Acta Psychiatrica Scandinavica, International Clinical Psychopharmacology and European Neuropsychopharmacology. Thompson Reuters named Dr. Leucht on their list of the World’s Most Influential Minds, as ranking in the top 1% citations for the field of psychiatry, and as a 2016 Highly Cited Researcher. He led the schizophrenia guideline group of the College of International Neuropsychopharmacology (CINP) and he holds a position of honorary professor of Evidence-based Psychopharmacology at the University of Aarhus, Denmark. He was awarded the David Sackett Award of the German Network of Evidence-Based Medicine in 2010, The American Psychiatric Association Young Minds in Psychiatry Award in 2004, and the Robert Kerwin Award of the Royal College of Psychiatry in 2012. The overarching theme of Dr. Leucht's research is and evidence-based medicine in psychiatry with a focus on meta-analyses, clinical trials and the improvement of methodology of studies in this area. He also has a research interest in pharmacogenetics, compliance enhancement strategies and medical decision making.